nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—Nausea—Mercaptopurine—hematologic cancer	0.000898	0.00124	CcSEcCtD
Molindone—Vision blurred—Alitretinoin—hematologic cancer	0.000896	0.00124	CcSEcCtD
Molindone—Leukopenia—Thalidomide—hematologic cancer	0.000894	0.00124	CcSEcCtD
Molindone—Tremor—Alitretinoin—hematologic cancer	0.000891	0.00123	CcSEcCtD
Molindone—Nausea—Clofarabine—hematologic cancer	0.000885	0.00122	CcSEcCtD
Molindone—Nausea—Daunorubicin—hematologic cancer	0.000885	0.00122	CcSEcCtD
Molindone—Vision blurred—Ifosfamide—hematologic cancer	0.000885	0.00122	CcSEcCtD
Molindone—Tachycardia—Bortezomib—hematologic cancer	0.000882	0.00122	CcSEcCtD
Molindone—Agitation—Carmustine—hematologic cancer	0.000882	0.00122	CcSEcCtD
Molindone—Nausea—Anagrelide—hematologic cancer	0.000882	0.00122	CcSEcCtD
Molindone—Nausea—Pentostatin—hematologic cancer	0.000882	0.00122	CcSEcCtD
Molindone—Weight increased—Triamcinolone—hematologic cancer	0.000879	0.00121	CcSEcCtD
Molindone—Rash—Teniposide—hematologic cancer	0.000878	0.00121	CcSEcCtD
Molindone—Dermatitis—Teniposide—hematologic cancer	0.000877	0.00121	CcSEcCtD
Molindone—Dyspnoea—Lenalidomide—hematologic cancer	0.000876	0.00121	CcSEcCtD
Molindone—Agitation—Alitretinoin—hematologic cancer	0.000874	0.00121	CcSEcCtD
Molindone—Somnolence—Lenalidomide—hematologic cancer	0.000873	0.00121	CcSEcCtD
Molindone—Dyspnoea—Hydroxyurea—hematologic cancer	0.000864	0.00119	CcSEcCtD
Molindone—Agitation—Ifosfamide—hematologic cancer	0.000863	0.00119	CcSEcCtD
Molindone—Tachycardia—Vinorelbine—hematologic cancer	0.000862	0.00119	CcSEcCtD
Molindone—Somnolence—Hydroxyurea—hematologic cancer	0.000861	0.00119	CcSEcCtD
Molindone—Leukopenia—Carmustine—hematologic cancer	0.000859	0.00119	CcSEcCtD
Molindone—Muscle spasms—Irinotecan—hematologic cancer	0.000858	0.00118	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—hematologic cancer	0.000855	0.00118	CcSEcCtD
Molindone—Nausea—Idarubicin—hematologic cancer	0.00085	0.00117	CcSEcCtD
Molindone—Hypotension—Bortezomib—hematologic cancer	0.000845	0.00117	CcSEcCtD
Molindone—Agitation—Vincristine—hematologic cancer	0.000842	0.00116	CcSEcCtD
Molindone—Leukopenia—Ifosfamide—hematologic cancer	0.000841	0.00116	CcSEcCtD
Molindone—Vision blurred—Mitoxantrone—hematologic cancer	0.000841	0.00116	CcSEcCtD
Molindone—Constipation—Lenalidomide—hematologic cancer	0.00084	0.00116	CcSEcCtD
Molindone—Hypotension—Bleomycin—hematologic cancer	0.000838	0.00116	CcSEcCtD
Molindone—Dry mouth—Thalidomide—hematologic cancer	0.000832	0.00115	CcSEcCtD
Molindone—Constipation—Hydroxyurea—hematologic cancer	0.000828	0.00114	CcSEcCtD
Molindone—Nausea—Teniposide—hematologic cancer	0.000827	0.00114	CcSEcCtD
Molindone—Hypotension—Vinorelbine—hematologic cancer	0.000825	0.00114	CcSEcCtD
Molindone—Tachycardia—Thiotepa—hematologic cancer	0.000823	0.00114	CcSEcCtD
Molindone—Leukopenia—Vincristine—hematologic cancer	0.00082	0.00113	CcSEcCtD
Molindone—Rash—Busulfan—hematologic cancer	0.000813	0.00112	CcSEcCtD
Molindone—Dermatitis—Busulfan—hematologic cancer	0.000813	0.00112	CcSEcCtD
Molindone—Dyspnoea—Bortezomib—hematologic cancer	0.000806	0.00111	CcSEcCtD
Molindone—Dyspnoea—Bleomycin—hematologic cancer	0.0008	0.00111	CcSEcCtD
Molindone—Leukopenia—Irinotecan—hematologic cancer	0.000798	0.0011	CcSEcCtD
Molindone—Leukopenia—Mitoxantrone—hematologic cancer	0.000798	0.0011	CcSEcCtD
Molindone—Weight increased—Dexamethasone—hematologic cancer	0.000798	0.0011	CcSEcCtD
Molindone—Weight increased—Betamethasone—hematologic cancer	0.000798	0.0011	CcSEcCtD
Molindone—Tachycardia—Thalidomide—hematologic cancer	0.000796	0.0011	CcSEcCtD
Molindone—Weight decreased—Dexamethasone—hematologic cancer	0.000793	0.0011	CcSEcCtD
Molindone—Weight decreased—Betamethasone—hematologic cancer	0.000793	0.0011	CcSEcCtD
Molindone—Dry mouth—Alitretinoin—hematologic cancer	0.000791	0.00109	CcSEcCtD
Molindone—Rash—Procarbazine—hematologic cancer	0.000789	0.00109	CcSEcCtD
Molindone—Dermatitis—Procarbazine—hematologic cancer	0.000788	0.00109	CcSEcCtD
Molindone—Dyspnoea—Vinorelbine—hematologic cancer	0.000787	0.00109	CcSEcCtD
Molindone—Muscle spasms—Cisplatin—hematologic cancer	0.000779	0.00108	CcSEcCtD
Molindone—Leukopenia—Gemcitabine—hematologic cancer	0.000778	0.00107	CcSEcCtD
Molindone—Rash—Dasatinib—hematologic cancer	0.000774	0.00107	CcSEcCtD
Molindone—Rash—Bexarotene—hematologic cancer	0.000774	0.00107	CcSEcCtD
Molindone—Constipation—Bortezomib—hematologic cancer	0.000773	0.00107	CcSEcCtD
Molindone—Dermatitis—Dasatinib—hematologic cancer	0.000773	0.00107	CcSEcCtD
Molindone—Dermatitis—Bexarotene—hematologic cancer	0.000773	0.00107	CcSEcCtD
Molindone—Rash—Fludarabine—hematologic cancer	0.000771	0.00107	CcSEcCtD
Molindone—Dermatitis—Fludarabine—hematologic cancer	0.000771	0.00106	CcSEcCtD
Molindone—Nausea—Busulfan—hematologic cancer	0.000766	0.00106	CcSEcCtD
Molindone—Tachycardia—Carmustine—hematologic cancer	0.000764	0.00106	CcSEcCtD
Molindone—Vision blurred—Cisplatin—hematologic cancer	0.000763	0.00105	CcSEcCtD
Molindone—Hypotension—Thalidomide—hematologic cancer	0.000762	0.00105	CcSEcCtD
Molindone—Tremor—Cisplatin—hematologic cancer	0.000759	0.00105	CcSEcCtD
Molindone—Tachycardia—Alitretinoin—hematologic cancer	0.000757	0.00105	CcSEcCtD
Molindone—Constipation—Vinorelbine—hematologic cancer	0.000755	0.00104	CcSEcCtD
Molindone—Somnolence—Thiotepa—hematologic cancer	0.000749	0.00104	CcSEcCtD
Molindone—Nausea—Procarbazine—hematologic cancer	0.000743	0.00103	CcSEcCtD
Molindone—Hypotension—Carmustine—hematologic cancer	0.000732	0.00101	CcSEcCtD
Molindone—Nausea—Dasatinib—hematologic cancer	0.000729	0.00101	CcSEcCtD
Molindone—Nausea—Bexarotene—hematologic cancer	0.000729	0.00101	CcSEcCtD
Molindone—Dyspnoea—Thalidomide—hematologic cancer	0.000727	0.001	CcSEcCtD
Molindone—Nausea—Fludarabine—hematologic cancer	0.000727	0.001	CcSEcCtD
Molindone—Leukopenia—Cisplatin—hematologic cancer	0.000725	0.001	CcSEcCtD
Molindone—Hypotension—Alitretinoin—hematologic cancer	0.000725	0.001	CcSEcCtD
Molindone—Somnolence—Thalidomide—hematologic cancer	0.000725	0.001	CcSEcCtD
Molindone—Constipation—Thiotepa—hematologic cancer	0.000721	0.000996	CcSEcCtD
Molindone—Hypotension—Ifosfamide—hematologic cancer	0.000716	0.00099	CcSEcCtD
Molindone—Rash—Nilotinib—hematologic cancer	0.000715	0.000988	CcSEcCtD
Molindone—Dermatitis—Nilotinib—hematologic cancer	0.000714	0.000987	CcSEcCtD
Molindone—Muscle spasms—Etoposide—hematologic cancer	0.000713	0.000986	CcSEcCtD
Molindone—Rash—Imatinib—hematologic cancer	0.000711	0.000982	CcSEcCtD
Molindone—Tachycardia—Mitoxantrone—hematologic cancer	0.000711	0.000982	CcSEcCtD
Molindone—Dermatitis—Imatinib—hematologic cancer	0.00071	0.000981	CcSEcCtD
Molindone—Hypotension—Vincristine—hematologic cancer	0.000699	0.000965	CcSEcCtD
Molindone—Rash—Cladribine—hematologic cancer	0.000698	0.000965	CcSEcCtD
Molindone—Dyspnoea—Carmustine—hematologic cancer	0.000698	0.000965	CcSEcCtD
Molindone—Dermatitis—Cladribine—hematologic cancer	0.000698	0.000964	CcSEcCtD
Molindone—Constipation—Thalidomide—hematologic cancer	0.000697	0.000963	CcSEcCtD
Molindone—Somnolence—Carmustine—hematologic cancer	0.000696	0.000962	CcSEcCtD
Molindone—Weight increased—Prednisone—hematologic cancer	0.000695	0.00096	CcSEcCtD
Molindone—Dyspnoea—Alitretinoin—hematologic cancer	0.000692	0.000956	CcSEcCtD
Molindone—Weight decreased—Prednisone—hematologic cancer	0.00069	0.000954	CcSEcCtD
Molindone—Vision blurred—Prednisolone—hematologic cancer	0.00069	0.000953	CcSEcCtD
Molindone—Somnolence—Alitretinoin—hematologic cancer	0.00069	0.000953	CcSEcCtD
Molindone—Nausea—Chlorambucil—hematologic cancer	0.000689	0.000951	CcSEcCtD
Molindone—Dyspnoea—Ifosfamide—hematologic cancer	0.000684	0.000944	CcSEcCtD
Molindone—Somnolence—Ifosfamide—hematologic cancer	0.000682	0.000942	CcSEcCtD
Molindone—Hypotension—Mitoxantrone—hematologic cancer	0.00068	0.00094	CcSEcCtD
Molindone—Hypotension—Irinotecan—hematologic cancer	0.00068	0.00094	CcSEcCtD
Molindone—Nausea—Nilotinib—hematologic cancer	0.000673	0.00093	CcSEcCtD
Molindone—Constipation—Carmustine—hematologic cancer	0.00067	0.000925	CcSEcCtD
Molindone—Nausea—Imatinib—hematologic cancer	0.00067	0.000925	CcSEcCtD
Molindone—Leukopenia—Etoposide—hematologic cancer	0.000664	0.000918	CcSEcCtD
Molindone—Constipation—Alitretinoin—hematologic cancer	0.000663	0.000917	CcSEcCtD
Molindone—Hypotension—Gemcitabine—hematologic cancer	0.000663	0.000916	CcSEcCtD
Molindone—Nausea—Cladribine—hematologic cancer	0.000658	0.000909	CcSEcCtD
Molindone—Constipation—Ifosfamide—hematologic cancer	0.000656	0.000906	CcSEcCtD
Molindone—Dyspnoea—Mitoxantrone—hematologic cancer	0.000649	0.000897	CcSEcCtD
Molindone—Dyspnoea—Irinotecan—hematologic cancer	0.000649	0.000897	CcSEcCtD
Molindone—Somnolence—Irinotecan—hematologic cancer	0.000647	0.000894	CcSEcCtD
Molindone—Somnolence—Mitoxantrone—hematologic cancer	0.000647	0.000894	CcSEcCtD
Molindone—Tachycardia—Cisplatin—hematologic cancer	0.000645	0.000891	CcSEcCtD
Molindone—Constipation—Vincristine—hematologic cancer	0.000639	0.000883	CcSEcCtD
Molindone—Rash—Melphalan—hematologic cancer	0.000637	0.00088	CcSEcCtD
Molindone—Dermatitis—Melphalan—hematologic cancer	0.000636	0.000879	CcSEcCtD
Molindone—Dyspnoea—Gemcitabine—hematologic cancer	0.000632	0.000874	CcSEcCtD
Molindone—Nausea—Vinblastine—hematologic cancer	0.000631	0.000872	CcSEcCtD
Molindone—Somnolence—Gemcitabine—hematologic cancer	0.00063	0.000871	CcSEcCtD
Molindone—Constipation—Mitoxantrone—hematologic cancer	0.000623	0.00086	CcSEcCtD
Molindone—Constipation—Irinotecan—hematologic cancer	0.000623	0.00086	CcSEcCtD
Molindone—Rash—Lenalidomide—hematologic cancer	0.000619	0.000856	CcSEcCtD
Molindone—Dermatitis—Lenalidomide—hematologic cancer	0.000619	0.000855	CcSEcCtD
Molindone—Hypotension—Cisplatin—hematologic cancer	0.000618	0.000853	CcSEcCtD
Molindone—Rash—Hydroxyurea—hematologic cancer	0.000611	0.000844	CcSEcCtD
Molindone—Dermatitis—Hydroxyurea—hematologic cancer	0.00061	0.000843	CcSEcCtD
Molindone—Constipation—Gemcitabine—hematologic cancer	0.000606	0.000838	CcSEcCtD
Molindone—Nausea—Melphalan—hematologic cancer	0.0006	0.000829	CcSEcCtD
Molindone—Dysphagia—Epirubicin—hematologic cancer	0.000597	0.000825	CcSEcCtD
Molindone—Tachycardia—Etoposide—hematologic cancer	0.000591	0.000817	CcSEcCtD
Molindone—Dyspnoea—Cisplatin—hematologic cancer	0.000589	0.000814	CcSEcCtD
Molindone—Nausea—Lenalidomide—hematologic cancer	0.000584	0.000806	CcSEcCtD
Molindone—Tachycardia—Prednisolone—hematologic cancer	0.000583	0.000805	CcSEcCtD
Molindone—Nausea—Hydroxyurea—hematologic cancer	0.000575	0.000795	CcSEcCtD
Molindone—Rash—Bortezomib—hematologic cancer	0.00057	0.000788	CcSEcCtD
Molindone—Dermatitis—Bortezomib—hematologic cancer	0.000569	0.000787	CcSEcCtD
Molindone—Drowsiness—Methotrexate—hematologic cancer	0.000569	0.000786	CcSEcCtD
Molindone—Hypotension—Etoposide—hematologic cancer	0.000566	0.000782	CcSEcCtD
Molindone—Rash—Bleomycin—hematologic cancer	0.000566	0.000782	CcSEcCtD
Molindone—Dermatitis—Bleomycin—hematologic cancer	0.000565	0.000781	CcSEcCtD
Molindone—Dry mouth—Triamcinolone—hematologic cancer	0.00056	0.000774	CcSEcCtD
Molindone—Rash—Vinorelbine—hematologic cancer	0.000557	0.000769	CcSEcCtD
Molindone—Dermatitis—Vinorelbine—hematologic cancer	0.000556	0.000768	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—hematologic cancer	0.000552	0.000763	CcSEcCtD
Molindone—Weight increased—Epirubicin—hematologic cancer	0.000543	0.000751	CcSEcCtD
Molindone—Weight decreased—Epirubicin—hematologic cancer	0.00054	0.000746	CcSEcCtD
Molindone—Dyspnoea—Etoposide—hematologic cancer	0.00054	0.000746	CcSEcCtD
Molindone—Somnolence—Etoposide—hematologic cancer	0.000538	0.000744	CcSEcCtD
Molindone—Nausea—Bortezomib—hematologic cancer	0.000537	0.000742	CcSEcCtD
Molindone—Tachycardia—Triamcinolone—hematologic cancer	0.000536	0.000741	CcSEcCtD
Molindone—Nausea—Bleomycin—hematologic cancer	0.000533	0.000736	CcSEcCtD
Molindone—Drowsiness—Epirubicin—hematologic cancer	0.000532	0.000735	CcSEcCtD
Molindone—Rash—Thiotepa—hematologic cancer	0.000532	0.000734	CcSEcCtD
Molindone—Dermatitis—Thiotepa—hematologic cancer	0.000531	0.000734	CcSEcCtD
Molindone—Nausea—Vinorelbine—hematologic cancer	0.000524	0.000724	CcSEcCtD
Molindone—Constipation—Etoposide—hematologic cancer	0.000518	0.000715	CcSEcCtD
Molindone—Rash—Thalidomide—hematologic cancer	0.000514	0.00071	CcSEcCtD
Molindone—Dermatitis—Thalidomide—hematologic cancer	0.000514	0.00071	CcSEcCtD
Molindone—Weight increased—Doxorubicin—hematologic cancer	0.000503	0.000694	CcSEcCtD
Molindone—Vision blurred—Prednisone—hematologic cancer	0.000501	0.000692	CcSEcCtD
Molindone—Nausea—Thiotepa—hematologic cancer	0.000501	0.000692	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—hematologic cancer	0.0005	0.00069	CcSEcCtD
Molindone—Rash—Carmustine—hematologic cancer	0.000494	0.000682	CcSEcCtD
Molindone—Dermatitis—Carmustine—hematologic cancer	0.000493	0.000682	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—hematologic cancer	0.000492	0.00068	CcSEcCtD
Molindone—Dyspnoea—Triamcinolone—hematologic cancer	0.00049	0.000677	CcSEcCtD
Molindone—Rash—Alitretinoin—hematologic cancer	0.000489	0.000676	CcSEcCtD
Molindone—Agitation—Prednisone—hematologic cancer	0.000489	0.000675	CcSEcCtD
Molindone—Dermatitis—Alitretinoin—hematologic cancer	0.000489	0.000675	CcSEcCtD
Molindone—Tachycardia—Dexamethasone—hematologic cancer	0.000486	0.000672	CcSEcCtD
Molindone—Tachycardia—Betamethasone—hematologic cancer	0.000486	0.000672	CcSEcCtD
Molindone—Nausea—Thalidomide—hematologic cancer	0.000484	0.000669	CcSEcCtD
Molindone—Rash—Ifosfamide—hematologic cancer	0.000483	0.000668	CcSEcCtD
Molindone—Dermatitis—Ifosfamide—hematologic cancer	0.000483	0.000667	CcSEcCtD
Molindone—Rash—Vincristine—hematologic cancer	0.000471	0.000651	CcSEcCtD
Molindone—Dermatitis—Vincristine—hematologic cancer	0.000471	0.000651	CcSEcCtD
Molindone—Hypotension—Dexamethasone—hematologic cancer	0.000466	0.000643	CcSEcCtD
Molindone—Hypotension—Betamethasone—hematologic cancer	0.000466	0.000643	CcSEcCtD
Molindone—Nausea—Carmustine—hematologic cancer	0.000465	0.000643	CcSEcCtD
Molindone—Nausea—Alitretinoin—hematologic cancer	0.000461	0.000637	CcSEcCtD
Molindone—Rash—Irinotecan—hematologic cancer	0.000459	0.000634	CcSEcCtD
Molindone—Rash—Mitoxantrone—hematologic cancer	0.000459	0.000634	CcSEcCtD
Molindone—Dermatitis—Mitoxantrone—hematologic cancer	0.000459	0.000634	CcSEcCtD
Molindone—Dermatitis—Irinotecan—hematologic cancer	0.000459	0.000634	CcSEcCtD
Molindone—Nausea—Ifosfamide—hematologic cancer	0.000455	0.000629	CcSEcCtD
Molindone—Rash—Gemcitabine—hematologic cancer	0.000447	0.000618	CcSEcCtD
Molindone—Dermatitis—Gemcitabine—hematologic cancer	0.000447	0.000617	CcSEcCtD
Molindone—Nausea—Vincristine—hematologic cancer	0.000444	0.000613	CcSEcCtD
Molindone—Nausea—Mitoxantrone—hematologic cancer	0.000432	0.000597	CcSEcCtD
Molindone—Nausea—Irinotecan—hematologic cancer	0.000432	0.000597	CcSEcCtD
Molindone—Tachycardia—Prednisone—hematologic cancer	0.000424	0.000585	CcSEcCtD
Molindone—Nausea—Gemcitabine—hematologic cancer	0.000421	0.000582	CcSEcCtD
Molindone—Vision blurred—Methotrexate—hematologic cancer	0.000419	0.000579	CcSEcCtD
Molindone—Rash—Cisplatin—hematologic cancer	0.000417	0.000576	CcSEcCtD
Molindone—Dermatitis—Cisplatin—hematologic cancer	0.000416	0.000575	CcSEcCtD
Molindone—Muscle spasms—Epirubicin—hematologic cancer	0.0004	0.000552	CcSEcCtD
Molindone—Leukopenia—Methotrexate—hematologic cancer	0.000398	0.00055	CcSEcCtD
Molindone—Nausea—Cisplatin—hematologic cancer	0.000393	0.000542	CcSEcCtD
Molindone—Vision blurred—Epirubicin—hematologic cancer	0.000392	0.000542	CcSEcCtD
Molindone—Agitation—Epirubicin—hematologic cancer	0.000382	0.000528	CcSEcCtD
Molindone—Rash—Etoposide—hematologic cancer	0.000382	0.000528	CcSEcCtD
Molindone—Dermatitis—Etoposide—hematologic cancer	0.000381	0.000527	CcSEcCtD
Molindone—Rash—Prednisolone—hematologic cancer	0.000377	0.00052	CcSEcCtD
Molindone—Dermatitis—Prednisolone—hematologic cancer	0.000376	0.00052	CcSEcCtD
Molindone—Leukopenia—Epirubicin—hematologic cancer	0.000372	0.000514	CcSEcCtD
Molindone—Constipation—Prednisone—hematologic cancer	0.000371	0.000513	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—hematologic cancer	0.00037	0.000511	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—hematologic cancer	0.000363	0.000501	CcSEcCtD
Molindone—Nausea—Etoposide—hematologic cancer	0.00036	0.000497	CcSEcCtD
Molindone—Nausea—Prednisolone—hematologic cancer	0.000355	0.00049	CcSEcCtD
Molindone—Agitation—Doxorubicin—hematologic cancer	0.000354	0.000489	CcSEcCtD
Molindone—Rash—Triamcinolone—hematologic cancer	0.000346	0.000478	CcSEcCtD
Molindone—Dry mouth—Epirubicin—hematologic cancer	0.000346	0.000478	CcSEcCtD
Molindone—Dermatitis—Triamcinolone—hematologic cancer	0.000346	0.000478	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—hematologic cancer	0.000344	0.000476	CcSEcCtD
Molindone—Hypotension—Methotrexate—hematologic cancer	0.000339	0.000468	CcSEcCtD
Molindone—Tachycardia—Epirubicin—hematologic cancer	0.000331	0.000458	CcSEcCtD
Molindone—Nausea—Triamcinolone—hematologic cancer	0.000326	0.000451	CcSEcCtD
Molindone—Dyspnoea—Methotrexate—hematologic cancer	0.000323	0.000447	CcSEcCtD
Molindone—Somnolence—Methotrexate—hematologic cancer	0.000322	0.000446	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—hematologic cancer	0.00032	0.000443	CcSEcCtD
Molindone—Hypotension—Epirubicin—hematologic cancer	0.000317	0.000438	CcSEcCtD
Molindone—Rash—Betamethasone—hematologic cancer	0.000314	0.000434	CcSEcCtD
Molindone—Rash—Dexamethasone—hematologic cancer	0.000314	0.000434	CcSEcCtD
Molindone—Dermatitis—Dexamethasone—hematologic cancer	0.000314	0.000434	CcSEcCtD
Molindone—Dermatitis—Betamethasone—hematologic cancer	0.000314	0.000434	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—hematologic cancer	0.000307	0.000424	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—hematologic cancer	0.000303	0.000418	CcSEcCtD
Molindone—Somnolence—Epirubicin—hematologic cancer	0.000302	0.000417	CcSEcCtD
Molindone—Nausea—Dexamethasone—hematologic cancer	0.000296	0.000409	CcSEcCtD
Molindone—Nausea—Betamethasone—hematologic cancer	0.000296	0.000409	CcSEcCtD
Molindone—Hypotension—Doxorubicin—hematologic cancer	0.000293	0.000405	CcSEcCtD
Molindone—Constipation—Epirubicin—hematologic cancer	0.00029	0.000401	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—hematologic cancer	0.00028	0.000387	CcSEcCtD
Molindone—Somnolence—Doxorubicin—hematologic cancer	0.000279	0.000386	CcSEcCtD
Molindone—Rash—Prednisone—hematologic cancer	0.000274	0.000378	CcSEcCtD
Molindone—Dermatitis—Prednisone—hematologic cancer	0.000273	0.000378	CcSEcCtD
Molindone—Constipation—Doxorubicin—hematologic cancer	0.000269	0.000371	CcSEcCtD
Molindone—Nausea—Prednisone—hematologic cancer	0.000258	0.000356	CcSEcCtD
Molindone—Rash—Methotrexate—hematologic cancer	0.000229	0.000316	CcSEcCtD
Molindone—Dermatitis—Methotrexate—hematologic cancer	0.000228	0.000316	CcSEcCtD
Molindone—Nausea—Methotrexate—hematologic cancer	0.000215	0.000298	CcSEcCtD
Molindone—Rash—Epirubicin—hematologic cancer	0.000214	0.000296	CcSEcCtD
Molindone—Dermatitis—Epirubicin—hematologic cancer	0.000214	0.000295	CcSEcCtD
Molindone—Nausea—Epirubicin—hematologic cancer	0.000202	0.000279	CcSEcCtD
Molindone—Rash—Doxorubicin—hematologic cancer	0.000198	0.000274	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—hematologic cancer	0.000198	0.000273	CcSEcCtD
Molindone—Nausea—Doxorubicin—hematologic cancer	0.000187	0.000258	CcSEcCtD
Molindone—HTR2A—Signaling Pathways—PIK3CG—hematologic cancer	2.31e-05	8.35e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KIT—hematologic cancer	2.31e-05	8.35e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—NRAS—hematologic cancer	2.31e-05	8.35e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PTPN11—hematologic cancer	2.3e-05	8.34e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CD80—hematologic cancer	2.3e-05	8.32e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	2.3e-05	8.32e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	2.29e-05	8.31e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KIT—hematologic cancer	2.29e-05	8.31e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	2.29e-05	8.31e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGFR3—hematologic cancer	2.29e-05	8.28e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EP300—hematologic cancer	2.27e-05	8.24e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PTPN11—hematologic cancer	2.27e-05	8.21e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK14—hematologic cancer	2.26e-05	8.19e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	2.25e-05	8.16e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—FGF2—hematologic cancer	2.25e-05	8.14e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	2.24e-05	8.13e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CREB1—hematologic cancer	2.23e-05	8.08e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ESR1—hematologic cancer	2.22e-05	8.04e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	2.22e-05	8.03e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—SRC—hematologic cancer	2.21e-05	8.01e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK3—hematologic cancer	2.21e-05	8e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CD—hematologic cancer	2.21e-05	7.99e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—BRAF—hematologic cancer	2.2e-05	7.98e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	2.2e-05	7.96e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CREB1—hematologic cancer	2.2e-05	7.95e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FN1—hematologic cancer	2.19e-05	7.94e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CREB1—hematologic cancer	2.18e-05	7.91e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL2—hematologic cancer	2.18e-05	7.91e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—hematologic cancer	2.18e-05	7.89e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6R—hematologic cancer	2.18e-05	7.88e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CREBBP—hematologic cancer	2.17e-05	7.87e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—BRAF—hematologic cancer	2.17e-05	7.85e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—BAD—hematologic cancer	2.17e-05	7.85e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NFKBIA—hematologic cancer	2.17e-05	7.85e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—BRAF—hematologic cancer	2.16e-05	7.81e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VEGFA—hematologic cancer	2.15e-05	7.8e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—JAK2—hematologic cancer	2.15e-05	7.8e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL2—hematologic cancer	2.15e-05	7.78e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOTCH1—hematologic cancer	2.15e-05	7.77e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6R—hematologic cancer	2.14e-05	7.76e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	2.14e-05	7.74e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL2—hematologic cancer	2.14e-05	7.74e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—STAT3—hematologic cancer	2.13e-05	7.73e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6R—hematologic cancer	2.13e-05	7.71e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NRAS—hematologic cancer	2.13e-05	7.71e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	2.13e-05	7.7e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	2.11e-05	7.64e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MDM2—hematologic cancer	2.1e-05	7.61e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CD80—hematologic cancer	2.1e-05	7.61e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CG—hematologic cancer	2.1e-05	7.6e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KIT—hematologic cancer	2.1e-05	7.6e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—NRAS—hematologic cancer	2.1e-05	7.6e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3R1—hematologic cancer	2.08e-05	7.54e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	2.07e-05	7.51e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PTPN11—hematologic cancer	2.06e-05	7.47e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	2.06e-05	7.46e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MTOR—hematologic cancer	2.05e-05	7.41e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	2.05e-05	7.41e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.04e-05	7.39e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	2.04e-05	7.39e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK3—hematologic cancer	2.04e-05	7.38e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.03e-05	7.35e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	2.03e-05	7.34e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—KRAS—hematologic cancer	2.02e-05	7.31e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.02e-05	7.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK3—hematologic cancer	2.01e-05	7.28e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	2.01e-05	7.27e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2e-05	7.23e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CREB1—hematologic cancer	2e-05	7.23e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	1.98e-05	7.19e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MYC—hematologic cancer	1.98e-05	7.18e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TGFB1—hematologic cancer	1.98e-05	7.16e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	1.97e-05	7.15e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FGF2—hematologic cancer	1.97e-05	7.14e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—BRAF—hematologic cancer	1.97e-05	7.14e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL2—hematologic cancer	1.95e-05	7.08e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	1.95e-05	7.07e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6R—hematologic cancer	1.95e-05	7.06e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	1.95e-05	7.05e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CREBBP—hematologic cancer	1.95e-05	7.05e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FGF2—hematologic cancer	1.94e-05	7.03e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FGF2—hematologic cancer	1.93e-05	6.99e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CB—hematologic cancer	1.92e-05	6.96e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	1.92e-05	6.95e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	1.91e-05	6.93e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	1.9e-05	6.9e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	1.9e-05	6.88e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—JAK2—hematologic cancer	1.89e-05	6.85e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—hematologic cancer	1.88e-05	6.81e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL2—hematologic cancer	1.88e-05	6.8e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—hematologic cancer	1.87e-05	6.77e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—JAK2—hematologic cancer	1.86e-05	6.74e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	1.86e-05	6.72e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	1.85e-05	6.71e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—JAK2—hematologic cancer	1.85e-05	6.7e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MDM2—hematologic cancer	1.85e-05	6.69e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	1.84e-05	6.68e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—KRAS—hematologic cancer	1.83e-05	6.63e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCND1—hematologic cancer	1.83e-05	6.63e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—JUN—hematologic cancer	1.83e-05	6.62e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.83e-05	6.62e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.82e-05	6.6e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MDM2—hematologic cancer	1.82e-05	6.58e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.81e-05	6.57e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MDM2—hematologic cancer	1.81e-05	6.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	1.81e-05	6.54e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MTOR—hematologic cancer	1.8e-05	6.5e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	1.8e-05	6.5e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	1.77e-05	6.42e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PTEN—hematologic cancer	1.77e-05	6.4e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MTOR—hematologic cancer	1.77e-05	6.4e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	1.77e-05	6.4e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	1.77e-05	6.4e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MTOR—hematologic cancer	1.76e-05	6.37e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	1.76e-05	6.37e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	1.74e-05	6.31e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	1.73e-05	6.26e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	1.72e-05	6.25e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—HRAS—hematologic cancer	1.71e-05	6.21e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	1.69e-05	6.13e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	1.69e-05	6.11e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EP300—hematologic cancer	1.69e-05	6.1e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	1.69e-05	6.1e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CA—hematologic cancer	1.68e-05	6.09e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	1.68e-05	6.08e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	1.67e-05	6.04e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTEN—hematologic cancer	1.66e-05	6.02e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.66e-05	6.01e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	1.66e-05	6.01e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	1.65e-05	5.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—hematologic cancer	1.65e-05	5.98e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	1.65e-05	5.97e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL2—hematologic cancer	1.65e-05	5.97e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—hematologic cancer	1.64e-05	5.94e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	1.64e-05	5.94e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—SRC—hematologic cancer	1.64e-05	5.94e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	1.63e-05	5.91e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TP53—hematologic cancer	1.63e-05	5.9e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—hematologic cancer	1.63e-05	5.89e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL2—hematologic cancer	1.62e-05	5.88e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—hematologic cancer	1.62e-05	5.85e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—hematologic cancer	1.61e-05	5.85e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL2—hematologic cancer	1.61e-05	5.85e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.61e-05	5.82e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	1.61e-05	5.82e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	1.61e-05	5.82e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—hematologic cancer	1.61e-05	5.82e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—JUN—hematologic cancer	1.6e-05	5.81e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	1.6e-05	5.78e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—EP300—hematologic cancer	1.58e-05	5.74e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCND1—hematologic cancer	1.58e-05	5.73e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—STAT3—hematologic cancer	1.58e-05	5.73e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—JUN—hematologic cancer	1.58e-05	5.72e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NRAS—hematologic cancer	1.58e-05	5.71e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCND1—hematologic cancer	1.57e-05	5.7e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—JUN—hematologic cancer	1.57e-05	5.69e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HRAS—hematologic cancer	1.56e-05	5.64e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.56e-05	5.63e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.55e-05	5.62e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	1.53e-05	5.56e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	1.53e-05	5.54e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PTEN—hematologic cancer	1.53e-05	5.53e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.52e-05	5.51e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PTEN—hematologic cancer	1.52e-05	5.5e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.52e-05	5.5e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.51e-05	5.48e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	1.51e-05	5.47e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.51e-05	5.46e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	1.49e-05	5.41e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.49e-05	5.41e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—hematologic cancer	1.49e-05	5.4e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	1.49e-05	5.4e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	1.49e-05	5.38e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	1.48e-05	5.37e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EP300—hematologic cancer	1.48e-05	5.36e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.48e-05	5.36e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.48e-05	5.35e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.47e-05	5.32e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.47e-05	5.32e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.47e-05	5.31e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.46e-05	5.27e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EP300—hematologic cancer	1.45e-05	5.25e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.44e-05	5.21e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—SRC—hematologic cancer	1.44e-05	5.21e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.44e-05	5.2e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.42e-05	5.13e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—SRC—hematologic cancer	1.41e-05	5.1e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.4e-05	5.08e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.39e-05	5.04e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.39e-05	5.03e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.39e-05	5.03e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.38e-05	5.01e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.38e-05	5e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—hematologic cancer	1.37e-05	4.98e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	1.37e-05	4.97e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.37e-05	4.95e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.36e-05	4.93e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.36e-05	4.92e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—STAT3—hematologic cancer	1.36e-05	4.92e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.36e-05	4.92e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.36e-05	4.91e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NRAS—hematologic cancer	1.35e-05	4.91e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.33e-05	4.8e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.32e-05	4.8e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.3e-05	4.73e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	1.3e-05	4.7e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MYC—hematologic cancer	1.29e-05	4.67e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.29e-05	4.67e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.29e-05	4.66e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.27e-05	4.6e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.27e-05	4.58e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MYC—hematologic cancer	1.26e-05	4.57e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	1.26e-05	4.56e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.25e-05	4.54e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.25e-05	4.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.24e-05	4.5e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.24e-05	4.49e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.21e-05	4.37e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.19e-05	4.32e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.19e-05	4.3e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.17e-05	4.25e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.17e-05	4.24e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KRAS—hematologic cancer	1.17e-05	4.22e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.15e-05	4.18e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.15e-05	4.18e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.15e-05	4.17e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.1e-05	4e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.09e-05	3.97e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.08e-05	3.9e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.07e-05	3.88e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	1.07e-05	3.86e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TP53—hematologic cancer	1.06e-05	3.84e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.04e-05	3.77e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TP53—hematologic cancer	1.04e-05	3.75e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.02e-05	3.69e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.01e-05	3.67e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HRAS—hematologic cancer	9.97e-06	3.61e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HRAS—hematologic cancer	9.91e-06	3.59e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	9.8e-06	3.55e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—hematologic cancer	9.69e-06	3.51e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—hematologic cancer	9.57e-06	3.47e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—hematologic cancer	9.54e-06	3.45e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—hematologic cancer	9.49e-06	3.44e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TP53—hematologic cancer	9.48e-06	3.43e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	9.07e-06	3.28e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—hematologic cancer	8.94e-06	3.24e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—hematologic cancer	8.8e-06	3.19e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—hematologic cancer	8.75e-06	3.17e-05	CbGpPWpGaD
Molindone—HTR1A—hematopoietic system—hematologic cancer	8.72e-06	0.0913	CbGeAlD
Molindone—ADRA2A—Signaling Pathways—IL6—hematologic cancer	8.68e-06	3.14e-05	CbGpPWpGaD
Molindone—HTR7—hematopoietic system—hematologic cancer	8.33e-06	0.0873	CbGeAlD
Molindone—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	8.01e-06	2.9e-05	CbGpPWpGaD
Molindone—HTR7—gonad—hematologic cancer	6.34e-06	0.0664	CbGeAlD
Molindone—ADRA2A—hematopoietic system—hematologic cancer	6.11e-06	0.064	CbGeAlD
Molindone—CHRM1—lung—hematologic cancer	5.68e-06	0.0595	CbGeAlD
Molindone—HTR7—blood—hematologic cancer	5.52e-06	0.0578	CbGeAlD
Molindone—HTR2A—hematopoietic system—hematologic cancer	5.2e-06	0.0544	CbGeAlD
Molindone—HTR7—lung—hematologic cancer	4.84e-06	0.0507	CbGeAlD
Molindone—ADRA2A—gonad—hematologic cancer	4.65e-06	0.0487	CbGeAlD
Molindone—DRD2—lung—hematologic cancer	4.58e-06	0.0479	CbGeAlD
Molindone—HTR7—testis—hematologic cancer	4.57e-06	0.0478	CbGeAlD
Molindone—DRD2—testis—hematologic cancer	4.32e-06	0.0452	CbGeAlD
Molindone—ADRA2A—blood—hematologic cancer	4.05e-06	0.0424	CbGeAlD
Molindone—HTR2A—gonad—hematologic cancer	3.95e-06	0.0414	CbGeAlD
Molindone—ADRA2A—lung—hematologic cancer	3.55e-06	0.0372	CbGeAlD
Molindone—HTR2A—blood—hematologic cancer	3.44e-06	0.0361	CbGeAlD
Molindone—ADRA2A—testis—hematologic cancer	3.35e-06	0.0351	CbGeAlD
Molindone—HTR2A—lung—hematologic cancer	3.02e-06	0.0316	CbGeAlD
Molindone—HTR2A—testis—hematologic cancer	2.85e-06	0.0298	CbGeAlD
Molindone—ADRA2A—lymph node—hematologic cancer	2.43e-06	0.0254	CbGeAlD
